Most cited article - PubMed ID 36117974
Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19
Acute manifestations of ischemic heart disease are among the most serious and fatal consequences of atherosclerotic processes. In this study, we hypothesized that a soluble proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble bone morphogenetic protein 4 (BMP-4), soluble E-selectin (sE-selectin), soluble endoglin (sENG) and soluble endocan (Endocan) would differ from healthy controls in myocardial infarction (MI) patients admitted to the hospital without any previous history of cardiovascular disease and with no cardioprotective drugs taken before admission. The study was conducted using a cross-sectional design. We analyzed data from 79 patients (mean age 54.1 ± 8.9, 18% of women) admitted for the first manifestation of MI and with no history of cardioprotective treatment use before the event. As a control group, we analyzed 17 age-matched healthy volunteers (mean age 51.5 ± 8.6, 47% of women). In addition to routinely obtaining clinical and laboratory data, we analyzed plasma concentrations of the aforementioned biomarkers using ELISA and Luminex analyses. Patients with MI did not differ from healthy controls in total cholesterol, LDL, non-HDL, and triglyceride levels. PCSK9, BMP-4, and sE-selectin levels did not differ significantly between the MI and the control group. Patients with MI had significantly higher sENG and Endocan levels than the control group. In addition, levels of sENG were significantly higher in patients with higher body mass index (BMI) and in smokers. We demonstrated that sENG could serve as a biomarker reflecting endothelial dysfunction in MI patients without prior treatment for cardiovascular risk factors.
- Keywords
- myocardial infarction, soluble endocan., soluble endoglin,
- MeSH
- Biomarkers blood MeSH
- Endothelium, Vascular * physiopathology pathology metabolism MeSH
- Adult MeSH
- E-Selectin blood MeSH
- Endoglin * blood MeSH
- Myocardial Infarction * blood pathology physiopathology MeSH
- Bone Morphogenetic Protein 4 blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Proteins blood MeSH
- Proprotein Convertase 9 blood MeSH
- Proteoglycans blood MeSH
- Cross-Sectional Studies MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
- Names of Substances
- Biomarkers MeSH
- BMP4 protein, human MeSH Browser
- E-Selectin MeSH
- Endoglin * MeSH
- ENG protein, human MeSH Browser
- ESM1 protein, human MeSH Browser
- Bone Morphogenetic Protein 4 MeSH
- Neoplasm Proteins MeSH
- PCSK9 protein, human MeSH Browser
- Proprotein Convertase 9 MeSH
- Proteoglycans MeSH
- SELE protein, human MeSH Browser